Transcript of Earnings Conference Call for Financial Performance for the 2nd Quarter and half year ended 30 September 2026

Ref. No: HSCL / Stock-Ex/2026-27/80 Date: 28/10/2026 E-mail: monika@himadri.com Ref: Listing Code: 500184 Ref: Listing Code: HSCL BSE Limited National Stock Exchange of India Ltd Department of Corporate Services Exchange Plaza, C-1, Block-G P. J. Towers, 25th Floor, Bandra Kurla Complex, Dalal Street, Bandra (E) Mumbai- 400 001 Mumbai- 400 051 Sub: Transcript of Earnings Conference Call for Financial Performance for the 2nd Quarter and Half Year ended 30 September 2026 held on Thursday, 22 October 2026 Dear Sir/ Madam, Further to our letters dated 16 October 2026 and 22 October 2026 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) read with Schedule III of the SEBI Listing Regulations and other applicable provisions of the SEBI Listing Regulations, we are enclosing herewith the transcript of earnings conference call for Financial Performance for the 2nd Quarter and half year ended 30 September 2026 held on Thursday, 22 October 2026 at 04:00 p.m. (IST). The above information will be made available on the Company’s website at www.himadri.com You are requested to take the same on record. Thanking you. Yours faithfully, For Himadri Speciality Chemical Ltd Monika Saraswat Company Secretary & Compliance Officer ACS: 29322 “Himadri Speciality Chemical Ltd Q2 FY27 Earnings Conference Call” October 22, 2026 MANAGEMENT: MR. ANURAG CHOUDHARY – CHAIRMAN, MANAGING DIRECTOR AND CHIEF EXECUTIVE OFFICER – HIMADRI SPECIALITY CHEMICAL LTD MR. SOMESH SATNALIKA – EXECUTIVE VICE PRESIDENT, TYRE AND STRATEGY – HIMADRI SPECIALITY CHEMICAL LTD Page 1 of 18 October 22, 2026 Himadri Speciality Chemical Ltd Moderator: Ladies and gentlemen, good day, and welcome to the Himadri Speciality Chemical Ltd Conference Call. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing star then zero on your touch-tone phone. Please note that this conference is being recorded. Today on the call, we have with us Mr. Anurag Choudhary, CMD and CEO; and Mr. Somesh Satnalika, EVP, Tyre and Strategy. Before we proceed with the call, I would like to give you a disclaimer that this conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions, and expectations as of today. Actual results may differ materially. The statements are not the guarantee of the future performance and involve risks and uncertainties that are difficult to predict. A detailed Safe Harbor statement is being given on Page number 2 of the Investors presentation of the company, which have been uploaded on the Stock Exchanges and on the company’s website. I now hand the conference over to Mr. Anurag Choudhary. Thank you, and over to you, sir. Anurag Choudhary: Thank you. Good evening, everyone, and thank you for joining us today. We deeply value your continued trust, confidence and engagement with Himadri. Q2 FY27 was another important quarter in Himadri's transformation journey. Several initiatives we have spoken about over the past several quarters are now translating from research to qualification, from capacity creation to customer engagement, and from strategic intent towards commercialisation. Before discussing these developments in detail, let me briefly touch upon our financial performance for the period ended 30th September 2026. For H1 FY27 on a consolidated basis, revenue surpassed INR 3,000 crores, EBITDA exceeded INR 600 crores and profit after tax crossed INR 450 crores. This performance reflects the strength of our business, an optimised product mix, operational efficiencies, and our continued focus on value-added products. Over the years, we have invested consistently in research and development, process engineering, manufacturing capabilities, customer relationships, and strategic partnerships. These investments are increasingly expanding our addressable markets, strengthening our competitive position and creating the foundation for next phase of Himadri's growth. Let me begin with the area where this transformation is perhaps most visible: speciality and advanced materials. Across our new material platforms, our focus remains clear: develop differentiated technologies, validate them rigorously with customers, and scale them in a disciplined manner. Our 200 TPA Carbon Nanotube facility remains targeted for commissioning in Q4 FY27. Carbon Nanotubes represent an important next-generation material with applications across lithium-ion batteries, semiconductors, electronics, conductive applications, and other high- performance uses. Page 2 of 18 October 22, 2026 Himadri Speciality Chemical Ltd In Super Speciality Carbon Black, our planned 6,000 TPA capacity remains targeted for Q4 FY28. This represents the next step in our journey from speciality carbon black to super speciality grades, towards highly engineered niche products designed for demanding applications. Our LFP cathode active materials roadmap is also progressing well with the initial 2,000 TPA capacity targeted for commissioning in Q3 FY27. The initial capacity is designed to support customer qualification and early commercial engagements, while also establishing the foundation for a significantly large scale-up opportunity. The progress in customer engagements together with strong visibility on future demand gives us confidence to move into the next phase of expansion with 40,000 TPA capacity planned for commissioning next year. On the anode side, our capabilities continue to progress across synthetic graphite and next- generation silicon carbon technologies, strengthening our objectives of building a comprehensive battery materials portfolio. We have already provided materials to leading domestic and global customers for their qualification process. Customers' feedback and engagements have been very encouraging. In anthraquinone and carbazole, our in-house engineering team has enabled us to accelerate execution with full capacity 5,300 TPA now targeted for commissioning together in Q4 FY27. The reason we are doing 2 phases together is there, that so in order to avoid any shutdown of 3 months during the commissioning of Phase 2. This allows us to bring the entire capacity to market in one shot, enabling faster market penetration and market share gains. As you all are aware, these expansions are focused largely on very high value-add categories and are therefore expected to have meaningful impact on company's profitability and margins. Importantly, let me inform you, all these developments are increasingly being complemented by deeper and more frequent customer engagements. During the quarter, we have entered into NDAs with Indian and international customers across Battery Materials, Carbon Nanotube (CNT) and Super Speciality Carbon Black segments. Our ENERGEX speciality carbon black grades received approval for high-voltage cable and battery applications followed by commercial orders. For us, this progression from research to qualification to customer relationship and commercial adoption thereafter is particularly important. It validates both the technology and the market opportunity. We continue to build ecosystem across lithium-ion battery value chain through our strategic investments and partnerships with a focus extending from material innovation and technology development to cell-level validation and eventual commercial deployments. During the quarter, we invested further in Sicona Battery Technologies. Sicona has also completed the acquisition of 100% of Advano in United States, adding valuable silicon anode intellectual property, a U.S.-based pilot plant facility and additional R&D and cell-testing capabilities. Further strengthening its commercialisation road map, Sicona has secured AUD45 million in funding f [Showing first 8,000 characters — download PDF for full document]